Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03446222

Epicardial Mini-Maze Versus Catheter Ablation for the Management of Persistent Atrial Fibrillation

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
The University of Texas Health Science Center, Houston · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will assess the efficacy of catheter ablation versus the Wolf Mini-Maze surgical ablation for rhythm control in patients with persistent afib.

Detailed description

Higher success rates have been achieved after a single surgical ablation when compared to catheter ablation, however contiguous and transmural lesions are not always guaranteed. Even though, catheter ablation is now being offered for symptomatic persistent AF, recurrence after the index procedure in such a persistent AF substrate is not unusual. Redo-catheter ablation is routinely offered for such patients; however long term success still remains low. Non-pulmonary vein triggers are often targeted in such redo-catheter ablation procedures; though this approach remains controversial. More recently, the Wolf Mini-Maze procedure has been utilized with promising results. This study proposes to randomize a group of persistent AF patients to undergo either catheter ablation or the surgical mini-maze procedure with left atrial appendage (LAA) ligation

Conditions

Interventions

TypeNameDescription
PROCEDURECatheter ablationCatheter based radiofrequency ablation with wide antral circumferential PVI and isolation of posterior wall will be performed. Mitral and cavo-tricuspid isthmus ablation will be done only if such isthumus dependent flutters are documented prior to / during the procedure.
PROCEDUREMini-maze surgical procedureWolf Mini-maze surgical ablation along with left atrial appendage ligation will be performed.

Timeline

Start date
2016-06-01
Primary completion
2017-12-01
Completion
2018-12-18
First posted
2018-02-26
Last updated
2018-02-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03446222. Inclusion in this directory is not an endorsement.